Sanna Bastiano
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Sanna Bastiano. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ACET | Award / Grant | 5,900 | — | — | Jun 1, 2023 | |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 422 | $350.03 | $147,713 | May 8, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 728 | $351.60 | $255,965 | May 2, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 4,068 | $326.45 | $1,327,999 | Apr 12, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 96 | $317.65 | $30,494 | Apr 4, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 1,466 | $313.74 | $459,943 | Mar 31, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 2,482 | $300.54 | $745,940 | Mar 16, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 3,970 | $289.12 | $1,147,806 | Feb 24, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 3,750 | $292.85 | $1,098,188 | Feb 17, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 1,902 | $300.29 | $571,152 | Feb 14, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 113 | $300.39 | $33,944 | Feb 10, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Award / Grant | 9,092 | — | — | Feb 1, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 106 | $325.00 | $34,450 | Jan 31, 2023 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 100 | $312.40 | $31,240 | Nov 2, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 1,503 | $300.02 | $450,930 | Oct 18, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 766 | $276.62 | $211,891 | Aug 1, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 8 | $254.44 | $2,036 | May 16, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 36 | $275.09 | $9,903 | May 4, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 43 | $258.46 | $11,114 | May 2, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 766 | $276.17 | $211,546 | Apr 29, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 30 | $277.02 | $8,311 | Apr 7, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 305 | $267.10 | $81,466 | Apr 5, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 1,344 | $263.09 | $353,593 | Apr 1, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 2,122 | $250.06 | $530,627 | Mar 17, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 3,439 | $232.51 | $799,602 | Feb 17, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 979 | $237.74 | $232,747 | Feb 10, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Award / Grant | 12,314 | — | — | Feb 1, 2022 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 766 | $185.07 | $141,764 | Nov 1, 2021 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 766 | $200.39 | $153,499 | Jul 30, 2021 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 47 | $216.88 | $10,193 | May 17, 2021 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 501 | $218.06 | $109,248 | Apr 30, 2021 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 389 | $214.99 | $83,631 | Apr 5, 2021 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 1,344 | $214.16 | $287,831 | Apr 1, 2021 |
| VRTX | EVP, Cell & Genetic Therapies | Sale | 1,469 | $210.44 | $309,136 | Feb 11, 2021 |
| VRTX | EVP, Cell & Genetic Therapies | Tax Withholding | 1,344 | $214.16 | $287,831 | Feb 10, 2021 |
| VRTX | EVP, Cell & Genetic Therapies | Award / Grant | 9,092 | — | — | Feb 3, 2021 |